Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 689 - 696 of 12140 results

New Schedule 13G Accelerated Filing Deadlines Effective Today, September 30, 2024

September 30, 2024| Alert| Viewpoint

Telephone and Texting Compliance News — September 2024

September 30, 2024| Article| Viewpoint

Telephone and Texting Compliance News: Regulatory Update — Federal Communications Commission to Consider New Call and Text Blocking Rules, Expand Other Requirements

September 30, 2024| Article| Viewpoint

Telephone and Texting Compliance News: Litigation Update — Florida Federal Court Upholds Prior Express Invitation and Draws Distinction to Section 227(b)

September 30, 2024| Article| Viewpoint

2024 Pre-Election Analysis: Financial Services

September 30, 2024| Advisory| Viewpoint

Mintz Venture Watch — Volume 7: A Report on Deal Trends from Q1 and Q2 2024

September 27, 2024| Article| Viewpoint

Qatar Added to List of ESTA/Visa Waiver Eligible Countries

September 27, 2024| Alert| Viewpoint

FTC Staff Report Warns of Privacy Risks in Social Media Companies’ AI Practices — AI: The Washington Report

September 26, 2024| Advisory| Viewpoint

News & Press Releases

Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber

September 15, 2025

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

Mintz Advises the Placement Agents in CAMP4’s up to $100 Million Private Placement

September 12, 2025

Mintz advised the placement agents in connection with CAMP4's up to $100 million private placement. The private placement included upfront gross proceeds of $50 million in exchange for common stock (and pre-funded warrants in lieu of common stock for certain investors). In addition, CAMP4 will be eligible to receive up to an additional $50 million in gross proceeds in exchange for common stock (and pre-funded warrants for certain investors), subject to achieving pre-specified milestones, including receipt of regulatory clearance to initiate a Phase 1/2 clinical trial in SYNGAP patients with its development candidate, CMP-SYNGAP-01.

View all News and Press Releases